A Houston-based compounding pharmacy that was recently roped into Eli Lilly’s fight against knockoff GLP-1s has landed in the FDA’s crosshairs for the second time in less than a year. | The FDA has ...

Empower Conservative Profile Fund earns an Average Process Pillar rating. The predominant contributor to the rating is the fund's strong long-term risk-adjusted performance. This can be seen in ...